Mylan Laboratories, Inc. v. Thompson

This document cites

• Federal Cases - Purepac Pharmaceutical Co. v. Thompson
• Federal Cases - Norwich Eaton Pharmaceuticals, Inc. v. Bowen
• Federal Cases - Ranbaxy Laboratories Ltd. v. U.S. Food & Drug Admin.
• Federal Cases - Unimed, Inc. v. Quigg
• Federal Cases - Mead Johnson Pharmaceutical Group, Mead Johnson & Co. v. Bowen, 87-5099



See all quotations

• Federal Cases - Eli Lilly and Company v. Medtronic, Inc
• Federal Cases - Bristol-Myers Squibb Co. v. Shalala
• Federal Cases - Skidmore v. Swift Co
• Federal Cases - Barr Laboratories, Inc. v. Thompson
• Federal Cases - Allergan, Inc. v. Alcon Laboratories, Inc.
• Federal Cases - Joyce v. Luther, 81-C-151.
• Federal Cases - Mova Pharmaceutical Corp. v. Shalala
• Federal Cases - Serono Laboratories, Inc. v. Shalala
• Federal Cases - Robert Wood Johnson University Hosp. v. Thompson
• Federal Cases - U.S. v Mead Corporation
• Federal Cases - Dr. Reddy's Laboratories, Inc. v. Thompson
• Federal Cases - Citizens To Preserve Overton Park, Inc v. Volpe
• Federal Cases - Valley Drug Co. v. Geneva Pharm., Inc.
• Federal Cases - Bayer v. U.S. Dept. of Treasury
• Federal Cases - Minnesota Mining and Mfg. v. Barr Laboratories
• Federal Cases - Alza Corp. v. Mylan Laboratories, Inc.
• Federal Cases - Andrx Pharmaceuticals Inc v. Biovail Corp
• Federal Cases - Chevron Inc v. Natural Resources Defense Council, Inc American Iron and Steel Institute v. Natural Resources Defense Council, Inc Ruckelshaus v. Natural Resources Defense Council, Inc
• Federal Cases - Adams Fruit Company, Inc v. Barrett
• US - Reference Stubs - Scope of review
• US - Reference Stubs - Infringement of patent
• US - Reference Stubs - Presumption of validity; defenses
• US - Reference Stubs - Notice of certification of invalidity, unenforceability, or noninfringement of a patent
• US - Reference Stubs - Extension of patent term
• US - Reference Stubs - New drugs
• US - Reference Stubs - Claim for Relief Arising under 35 U.S.C. Section 271(e)(2) or 42 U.S.C. Section 262
• US - Reference Stubs - Protection for drugs for rare diseases or conditions
• US - Reference Stubs - Short title
• US - Reference Stubs - Pediatric studies of drugs